Coexpression of CD44 and Ki-67 in colon`s neoplast

Close metadata

Recommended articles:

Comparative immunohistochemistry study of different antibodies clones for detection of breast cancer markers (estrogen receptor, progesterone receptor, HER2/neu, Ki-67). Russian Journal of Archive of Pathology. 2024;(2):14-20

Primary retroperitoneal approach for vessel-sparing D3-lymph node dissection in left colonic and rectal cancer resections — the first Russian experience. Pirogov Russian Journal of Surgery. 2023;(12):26-33

Efficiency and safety of cold snare polypectomy in patients with colon lesions ≤1.6 cm: two centers experience. Russian Journal of Evidence-Based Gastroenterology. 2023;(4):66-74

Clinical outcomes of colorectal stenting. Endoscopic Surgery. 2023;(6):12-18

Colorectal cancer screening: current status and future prospects. Russian Journal of Preventive Medicine. 2023;(12):12-18

Application of p16/Ki-67 double-stained immunohistochemistry in diagnosis of cervical intraepithelial lesions. Laboratory Service. 2023;(4):37-43

Socio-economic efficiency of the early cancer detection during the medical checkup. Russian Journal of Preventive Medicine. 2024;(1):36-44

Assessment of the association of the CYP1A1 gene RS1048943 polymorphism in the colorectal cancer: a meta-analysis. Russian Journal of Preventive Medicine. 2024;(2):37-43

Correction of anemia and mitochondrial dysfunction by iron citrate «Sintezit» during neoadjuvant chemotherapy for colorectal cancer and lymphoproliferative disorders. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):21-31

Colorectal cancer: incidence, risk factors, and screening. Russian Journal of Preventive Medicine. 2024;(3):93-97

Objective: the evaluation of Ki-67 and CD44 expression in the «serrated» polyps of the colon and comparison them with adenocarcinomas and tubular and tubule-villous adenomas of the colon. Material and methods. The study is including 49 «serrated» polyps, 34 tubular (AT) and tubulo-villous (ATV) adenomas and 32 adenocarcinomas of the colon. Antibodies CD44 and Ki-67 were used as immunohistochemical markers in this study. Results. A statistically significant difference (p<0.01) was observed between traditional serrated adenomas (TSA) from hyperplastic polyps (HP) and sessile serrated adenomas (SSA) in the Ki-67 level and the localization of the Ki-67 and CD44 reaction: surface areas of the crypts (upper third) in TSA and base of crypts (lower third) in HP and SSA. There was no difference between HP and SSA (p>0.05), neither by marker localization, nor by their level. In all «serrated» polyps of the colon, the Ki-67 reaction was nuclear; CD44 — membrane (except for 1 TSA). Conclusion: we are the first ones who suggested to evaluate not the overall level of reactions of CD44 and Ki-67, but particular level for each third part of crypts. The similarities of TSA, AT and ATV and between HP and SSA are shown as well as the principal statistical difference between these two groups. The cytoplasmic reaction of CD44 in adenocarcinomas and the membrane reaction of CD44 in 98% of the «serrated» polyps of the colon are described. For the first time coexpression of CD44 and Ki-67 on particulate thirds of crypts in neoplasms of the colon is shown and the potential reasons for this phenomenon are discussed.

Keywords:

«serrated» polyps of the colon

polyps of the colon

colorectal cancer

CD44

Ki-67

adenomas of the colon

hyperplastic polyp

sessile serrated adenoma

traditional serrated adenoma

coexpression

Authors:

Oleynikova N.А.

Lomonosov Moscow State University, Moscow, Russia

Kharlova O.A.

Russian Medical Academy of Postgraduate Education, Moscow

Mal'kov P.G.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova";
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

Danilova N.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava RF;
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

List of references:

Okamoto K, Kitamura S, Kimura T, Nakagawa T, Sogabe M, Miyamoto H, Muguruma N, Takayama T. Clinicopathological characteristics of serrated polyps as precursors to colorectal cancer: Current status and management. J Gastroenterol Hepatol. 2017;32(2):358-367. https://doi.org/10.1111/jgh.134
Snover D, Ahnen DJ, Burt RW, Odze RD, et al. Serrated polyps of the colon and rectum and serrated (hyperplastic) polyposis. In: Bozman FT, Carneiro F, Hruban RH, Thiese ND, eds. WHO Classification of tumours pathology and genetics tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010:160-5.
Caruso M, Fung KY, Moore J, Brierley GV, Cosgrove LJ, Thomas M, Cheetham G, Brook E, Fraser LM, Tin T, Tran H, Ruszkiewicz A. Claudin-1 expression is elevated in colorectal cancer precursor lesions harboring the BRAF V600E mutation. Transl Oncol. 2014;7(4):456-463. https://doi.org/10.1016/j.tranon.2014.05.009
Singh R, Zorron Cheng Tao Pu L, Koay D, Burt A. Sessile serrated adenoma/polyps: Where are we at in 2016? World J Gastroenterol. 2016;22(34):7754-9. https://doi.org/10.3748/wjg.v22.i34.7754
Arends MJ. Pathways of colorectal carcinogenesis. Appl Immunohistochem Mol Morphol. 2013;21(2):97-102. https://doi.org/10.1097/PAI.0b013e31827ea79e
Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM, Pearson SA, Klein K, Leggett BA, Whitehall V. A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol. 2015;28(3):414-427. https://doi.org/10.1038/modpathol.2014.122
Bordacahar B, Barret M, Terris B, Dhooge M, Dreanic J, Prat F, Coriat R, Chaussade S. Sessile serrated adenoma: from identification to resection. Dig Liver Dis. 2015;47(2):95-102. https://doi.org/10.1016/j.dld.2014.09.006
Grigor’ev EG, Vladimirova A A, Raevskaya LYu, Chashkova EYu. Zubchataya adenoma tolstoi kishki i ee klinicheskoe znachenie. Klinicheskaya meditsina. 2009;87(6):50-52. (In Russ.)
Mikhaleva LM, Komleva RA, Biryukov AE, Shakhlazyan NK. Serrated adenomas of the colon: Clinical, morphological, and molecular genetic characteristics. Arkhiv patologii. 2017;79(1):19-27. (In Russ.) https://doi.org/10.17116/patol201779119-27
Chai N, Zhang W, Wang Y, Zhou Z, Zhang Y, Liu H, Wan J, Qin J, Wang S, Wang Y, Pei X, Wu B, Linghu E. Lgr5 and CD44 expressions in different types of intestinal polyps and colorectal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(7):972-976.
Baker AM, Graham TA, Elia G, Wri6ght NA, Rodriguez-Justo M. Characterization of LGR5 stem cells in colorectal adenomas and carcinomas. Sci Rep. 2015;5:8654. https://doi.org/10.1038/srep08654
Fujimori Y, Fujimori T, Imura J, Sugai T, Yao T, Wada R, Ajioka Y, Ohkura Y. An assessment of the diagnostic criteria for sessile serrated adenoma/polyps: SSA/Ps using image processing software analysis for Ki67 immunohistochemistry. Diagn Pathol. 2012;7:59. https://doi.org/10.1186/1746-1596-7-59
Jiao YF, Nakamura S, Sugai T, Yamada N, Habano W. Serrated adenoma of the colorectum undergoes a proliferation versus differentiation process: new conceptual interpretation of morphogenesis. Oncology. 2008;74(3-4):127-134. https://doi.org/10.1159/000151359
Baker AM, Cereser B, Melton S, Fletcher AG, Rodriguez-Justo M, Tadrous PJ, Humphries A, Elia G, McDonald SA, Wright NA, Simons BD, Jansen M, Graham TA. Quantification of crypt and stem cell evolution in the normal and neoplastic human colon. Cell Rep. 2014;8(4):940-947. https://doi.org/10.1016/j.celrep.2014.07.019
Basakran NS. CD44 as a potential diagnostic tumor marker. Saudi Med J. 2015;36(3):273-279. https://doi.org/10.15537/smj.2015.3.9622
Miletti-Gonzalez KE, Murphy K, Kumaran MN, Ravindranath AK, Wernyj RP, Kaur S, Miles GD, Lim EChan R, Chekmareva M, Heller DS, Foran D, Chen W, Reiss M, Bandera EV, Scotto K, Rodriguez-Rodriguez L. Identification of function for CD44 intracytoplasmic domain (CD44-ICD): modulation of matrix metalloproteinase 9 (MMP-9) transcription via novel promoter response element. J Biol Chem. 2012;287(23):18995-9007. https://doi.org/10.1074/jbc.M111.318774
Khlebnikova AN, Gurevich LE, Korsakova NA, Ustinova EV. Molekuly adgezii CD44H v bazal’nokletochnom rake kozhi. Al’manakh klinicheskoi meditsiny. 2007;(15):292-295. (In Russ.)
Langner C. Serrated and non-serrated precursor lesions of colorectal cancer. Dig Dis (Basel, Switzerland). 2015;33(1):28-37. https://doi.org/10.1159/000366032
Moussata D, Boschetti G, Chauvenet M, Stroeymeyt K, Nancey S, Berger F, Lecomte T, Flourie B. Endoscopic and histologic characteristics of serrated lesions. World J Gastroenterol. 2015;21(10):2896-2904. https://doi.org/10.3748/wjg.v21.i10.2896
Collina F, Di Bonito M, Li Bergolis V, De Laurentiis M, Vitagliano C, Cerrone M, Nuzzo F, Cantile M, Botti G. Prognostic value of cancer stem cells markers in triple-negative breast cancer. Biomed Res Int. 2015;2015:158682. https://doi.org/10.1155/2015/158682
Chetty C, Vanamala SK, Gondi CS, Dinh DH, Gujrati M, Rao JS. MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal. 2012;24(2):549-559. https://doi.org/10.1016/j.cellsig.2011.10.008
Li X, Ma X, Chen L, Gu L, Zhang Y, Zhang F, Ouyang Y, Gao Y, Huang Q, Zhang X. Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis. Sci Rep. 2015;5:13157. https://doi.org/10.1038/srep13157
AbdElazeem MA, El-Sayed M. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia. Ann Diagn Pathol. 2015;19(6):369-374. https://doi.org/10.1016/j.anndiagpath.2015.08.004
Kharlova OA, Oleynikova NA, Mal`kov PG, Danilova NV, Popov PV. Comparative study of clinical and morphological characteristics of sessile serrated adenomas/ polyps and hyperplastic polyps of the colon and rectum. Ural’skii meditsinskii zhurnal. 2017;148(4):25-34. (In Russ.)
Bettington M, Walker N, Clouston A, Brown I, Leggett B, Whitehall V. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013;62(3):367-386. https://doi.org/10.1111/his.12055
Szylberg L, Janiczek M, Popiel A, Marszalek A. Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract. 2015;2015:573814. https://doi.org/10.1155/2015/573814
Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14(6):524-537.
Kharlova OA, Danilova NV, Mal`kov PG, Ageykina NV, Knyazev MV. Serrated lesions of the large bowel. Arkhiv patologii. 2015;77(1):60-68. (In Russ.) https://doi.org/10.17116/patol201577160
Nefedova NA, Kharlova OA, Mal`kov PG, Danilova NV. Immunohistochemical expression of markers assessment musashi- 1 in cancer and colon polyps Klinicheskaya i eksperimental’naya morfologiya. 2016;(1):4-10 (In Russ.)
Oleynikova NA, Kharlova OA, Mal`kov PG, Danilova NV. The expression of claudins in colonic neoplasms. Arkhiv patologii. 2017;79(1):28-35. (In Russ.) https://doi.org/10.17116/patol201779128-35
Kalimuthu SN, Chelliah A, Chetty R. From traditional serrated adenoma to tubulovillous adenoma and beyond. World J Gastrointest Oncol. 2016;8(12):805-809. https://doi.org/10.4251/wjgo.v8.i12.805
Buda A, De Bona M, Dotti I, Piselli P, Zabeo E, Barbazza R, Bellumat A, Valiante F, Nardon E, Probert CS, Pignatelli M, Stanta G, Sturniolo GC, De Boni M. Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol. 2012;3:e6. https://doi.org/10.1038/ctg.2011.5
Yang HM, Mitchell JM, Sepulveda JL, Sepulveda AR. Molecular and histologic considerations in the assessment of serrated polyps. Arch Pathol Lab Med. 2015;139(6):730-741. https://doi.org/10.5858/arpa.2014-0424-RA
Eissa AH, Sattar HA. Prognostic value of CD44 and Ki-67 in renal cell carcinoma. Med J Babylon. 2015;12(1). https://doi.org/1812-156X-12-1
Yildiz E, Gokce G, Kilicarslan H, Ayan S, Goze OF, Gultekin EY. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int. 2004;93(7):1087-93. https://doi.org/10.1111/j.1464-410X.2004.04786.x
Tenderenda M, Kupnicka D, Berner J, Wroński K. Immunohistochemical study on the prognostic value of CD44 antigen — marker of metastases — in gastric cancer and its correlation with selected molecular parameters. New Medicine. 2015;2:51-8. https://doi.org/10.5604/14270994.1169795
Myoteri D, Dellaportas D, Lykoudis PM, Apostolopoulos A, Marinis A, Zizi-Sermpetzoglou A. Prognostic evaluation of vimentin expression in correlation with Ki67 and CD44 in surgically resected pancreatic ductal adenocarcinoma. Gastroenterol Res Pract. 2017;2017:9207616. https://doi.org/10.1155/2017/9207616
Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol. 1999;154(2):515-23. https://doi.org/10.1016/s0002-9440(10)65297-2
Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma VM. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncol. 2007;43(1):51-59. https://doi.org/10.1016/j.oraloncology.2006.01.003
Trapasso S, Allegra E. Role of CD44 as a marker of cancer stem cells in head and neck cancer. Biologics. 2012;6:379-383. https://doi.org/10.2147/btt.s37906
Puglisi MA, Tesori V, Lattanzi W, Gasbarrini GB, Gasbarrini A. Colon cancer stem cells: controversies and perspectives. World J Gastroenterol. 2013;19(20):2997-3006. https://doi.org/10.3748/wjg.v19.i20.2997

Close metadata